试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-07
Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
编号:NCT03697551登记状态:提前终止企业 / 申办者:Ipsen
药物 / 成分:Satoreotide trizoxetan
登记的停止原因(原文):Recruitment challenges and not due to safety concerns.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-07
Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients
编号:NCT04522466登记状态:提前终止企业 / 申办者:Centre Hospitalier Universitaire de Saint Etienne
药物 / 成分:Hydroxychloroquine (HCQ)
登记的停止原因(原文):Stop of the study by competent authority (ANSM)
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
编号:NCT00799435登记状态:提前终止企业 / 申办者:Baylor College of Medicine
药物 / 成分:Exenatide
登记的停止原因(原文):Inability to recruit adequate Sample Size who met the entry criteria
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
编号:NCT01861561登记状态:提前终止企业 / 申办者:Mahidol University
药物 / 成分:Low-dose intravenous cyclophosphamide、High-dose intravenous cyclophosphamide
登记的停止原因(原文):The duration of the study is longer than 5 years and we can not recruit the participants to the target number.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
编号:NCT02057523登记状态:提前终止企业 / 申办者:University of Illinois Chicago
药物 / 成分:Acthar
登记的停止原因(原文):Unable to enroll patients, no longer at institution.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
编号:NCT02266147登记状态:提前终止企业 / 申办者:Dynavax Technologies Corporation
药物 / 成分:SD-101、Radiation therapy
登记的停止原因(原文):The sponsor terminated the trial early because there was sufficient data to make a decision about SD-101 in the lymphoma development program.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis
编号:NCT03015051登记状态:提前终止企业 / 申办者:IRCCS Burlo Garofolo
药物 / 成分:Oxygen
登记的停止原因(原文):Difficulty in recruiting subjects who meet the inclusion/exclusion criteria
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Manidipine Versus Amlodipine in Patients With Hypertension
编号:NCT03106597登记状态:提前终止企业 / 申办者:Korea University Guro Hospital
药物 / 成分:Manidipine 20mg、Amlodipine 10mg
登记的停止原因(原文):Difficulty in enrolling subjects
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
编号:NCT03221166登记状态:提前终止企业 / 申办者:IRCCS Burlo Garofolo
药物 / 成分:Thalidomide、Infliximab
登记的停止原因(原文):Difficulty in recruiting subjects who meet the inclusion/exclusion criteria
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2020-09-04
Comparison of Anesthesia Type in Patients Undergoing Transabdominal Cervico Isthmic Cerclage (TCIC)
编号:NCT03636048登记状态:提前终止企业 / 申办者:Hallym University Kangnam Sacred Heart Hospital
药物 / 成分:Bupivacaine Hcl 0.5% Inj、Propofol 10 milligram/ML
登记的停止原因(原文):not enough participants
查看官方原始记录 ↗